Table 1.

Clinical and demographic features of the cases

Clinical and demographic features	Patients with hematologic cancers (n = 463)	Patients with solid cancers (n = 463)	P value
Gender
Male, n (%)	256 (55.3%)	252 (54.4%)	0.8
Female, n (%)	207 (44.7%)	211 (45.6%)
Median age (years)	57 (18–93)	59 (19–86)	0.1
Comorbidity, n (%)
Diabetes mellitus	101 (21.8%)	78 (16.8%)	0.06
Hypertension	188 (40.6%)	183 (39.5%)	0.7
Cardiovascular diseases	59 (12.7%)	46 (9.9%)	0.2
Additional treatment, n (%)
Favipiravir	133 (28.7%)	61 (13.2%)	0.001*
Lopinavir/ritonavir	23 (5%)	15 (3.2%)	0.2
Hydroxychloroquine	332 (71.7%)	349 (75.4%)	0.2
High dose vitamin C	82 (17.7%)	56 (12.1%)	0.02*
Azithromycin	208 (44.9%)	208 (44.9%)	1